Siren »

Acelyrin shares owned by Siren

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Siren from 13F filings

Historical chart of Siren investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.5M 1.7M 4.93

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics (BCAX)
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin